NHS-Galleri Trial Design: Equitable study recruitment tactics for targeted population-level screening with a multi-cancer early detection (MCED) test.

Authors

null

Charles Swanton

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom

Charles Swanton , Richard D Neal , Peter W. M. Johnson , Christina Clarke Dur , Stephanie A Hamilton , Nan Zhang , Harpal Kumar , Peter Sasieni

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Health Services Research and Quality Improvement

Track

Quality Care/Health Services Research

Sub Track

Real-World Data/Outcomes

Clinical Trial Registration Number

ISRCTN91431511

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS6606)

DOI

10.1200/JCO.2022.40.16_suppl.TPS6606

Abstract #

TPS6606

Poster Bd #

385b

Abstract Disclosures

Similar Posters

First Author: Ayrton Bangolo

Poster

2020 ASCO Virtual Scientific Program

Mismatch between mortality burden and number of FDA registration trials in highly lethal cancers.

Mismatch between mortality burden and number of FDA registration trials in highly lethal cancers.

First Author: Bishal Gyawali

First Author: Bogda Koczwara